HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natura Considers Avon Separation; LVMH Highlights Sephora Growth In 2023; Beauty News In Brief

Executive Summary

Splitting off Avon as its own publicly traded company would unlock shareholder value and provide shareholders with greater visibility into the entities’ performance and potential, Natura says. Sephora sales fueled 20% reported growth in LVMH’s Selective Retailing business in 2023. More beauty news.

You may also be interested in...



Coty Continues Licensing Spree With Etro; CEO Nabi Shares Prestige Fragrance Vision

At CAGNY 2024, CEO Sue Nabi discussed Coty’s prestige fragrance strategy, including growing emphasis on ultra-premium offerings and continued focus on fashion-driven licenses, the same day the company announced a long-term fragrance licensing deal with Italian brand Etro.

CoverGirl TikTok Post With 95M Views Demonstrates Coty’s Rising Influencer Clout – CEO Nabi

CoverGirl Simply Ageless Skin Perfector Essence foundation was the focus of a TikTok influencer post that attracted 95m views, showing the power of Coty’s rapidly expanding influencer game, says CEO Sue Nabi. Nabi discussed the firm’s influencer strategy and results in the firm’s fiscal 2024 second quarter presentation.

Shiseido Reinforces US Position, Taps Dermocosmetics Growth With Dr. Dennis Gross Acquisition

Acquisition of the doctor-led “#1 At-Home Peel” brand continues Shiseido’s work to build its Americas business and strengthens its game in the dermocosmetics space, which has been growing fast since the pandemic. The firm’s net sales in the first nine months of 2023 increased 5% like-for-like to ¥722.4bn.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel